Cancer Therapy Advisor has partnered with leading medical publishers to present Publishers Alliance, a selection of oncology-focused articles from a number of clinically relevant research journals. 


Cachexia Index in Advanced Non-Small-Cell Lung Cancer Patients

Cachexia Index in Advanced Non-Small-Cell Lung Cancer Patients

[Clinical Medicine Insights: Oncology] Cancer cachexia affects many advanced non-small-cell lung cancer (NSCLC) patients.

Validation study of the modified injection technique for internal mammary sentinel lymph node biopsy in breast cancer

Validation study of the modified injection technique for internal mammary sentinel lymph node biopsy in breast cancer

[OncoTargets and Therapy] According to the hypothesis of internal mammary sentinel lymph node, lymphatic drainage pattern, a modified radiotracer injection technique was established.

Gemcitabine-Induced Pulmonary Toxicity: A Case Report of Pulmonary Veno-Occlusive Disease

Gemcitabine-Induced Pulmonary Toxicity: A Case Report of Pulmonary Veno-Occlusive Disease

[Clinical Medicine Insights: Oncology] Although myelosuppression is the most adverse event of this therapy, gemcitabine might induce severe pulmonary toxicities.

Imatinib in the treatment of chronic myeloid leukemia: current perspectives on optimal dose

Imatinib in the treatment of chronic myeloid leukemia: current perspectives on optimal dose

[Blood and Lymphatic Cancer Targets and Therapy] Imatinib was the first tyrosine kinase inhibitor (TKI), successfully used in a clinical setting.

Non-Hodgkin Lymphoma of the Stomach in a Patient Treated With Natalizumab

Non-Hodgkin Lymphoma of the Stomach in a Patient Treated With Natalizumab

[Clinical Medicine Insights: Oncology] Given the absence of association between multiple sclerosis, diffuse large B-cell lymphoma, causal association with natalizumab cannot be excluded.

Biomarkers in Hematological Malignancies: A Review of Molecular Testing in Hematopathology

Biomarkers in Hematological Malignancies: A Review of Molecular Testing in Hematopathology

[Cancer Control] Molecular testing is entrenched in the workup and management of hematological malignancies.

BRAF mutations in non-small cell lung cancer

BRAF mutations in non-small cell lung cancer

[Translational Lung Cancer Research] This research investigates the prevalence and clinicopathological features of BRAF mutations in non-small cell lung cancer (NSCLC) cases submitted for routine mutation testing.

CD151—A Striking Marker for Cancer Therapy

CD151—A Striking Marker for Cancer Therapy

[Biomarkers in Cancer] Cluster of differentiation 151 (CD151) functions at various stages of cancer, including metastatic cascade and primary tumor growth, reinforcing the importance of CD151 as a target in oncology.

Role of the WASP and WAVE family proteins in breast cancer invasion and metastasis

Role of the WASP and WAVE family proteins in breast cancer invasion and metastasis

[Breast Cancer: Targets and Therapy] This review focuses on the role of the WASP/WAVE family in breast cancer cell invasion and migration.

Threading the cloak: palliative care education for care providers of adolescents, young adults with cancer

Threading the cloak: palliative care education for care providers of adolescents, young adults with cancer

[Clinical Oncology in Adolescents and Young Adults] Integration of palliative care at the time of diagnosis enables a supportive partnership with the medical team.

Our Publishing Partners


ARE YOU A PUBLISHER LOOKING TO JOIN OUR PUBLISHERS ALLIANCE TEAM? FIND OUT MORE!


Your research articles may be of interest
to our wide-ranging audience of oncology professionals.


CLICK HERE to e-mail the Editor for more information!

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs

Sign Up for Free e-newsletters